Earlier today, President Trump announced a deal to drastically lower the price of some popular weight loss drugs for some Americans. Under the deal, Eli Lilly, the maker of Zepbound, and Novo Nordisk, the company behind Ozempic and Wegovy, have agreed to lower the price of their weight loss drugs for eligible patients on Medicare, Medicaid and for eligible users of the planned "TrumpRx" pharmaceutical website. "This will slash the cost of Wegovy from $1,350 a month to ultimately $250 a month," P

At just 21, Lilly Castillo made the decision to serve her country by joining the United States Air Force. For six years, she worked alongside the Army, helping forecast the weather to keep missions safe. When it was time to return to civilian life, Team Rubicon was there to guide her through the transition — empowering Lilly to continue serving, this time by helping her community rebuild and thrive. NCIS, @lovesac and @vizio present #TuesdaysofHonor with @teamrubicon — a campaign celebrating rea

President Donald Trump announces an agreement with drugmakers Novo Nordisk and Eli Lilly to lower the cost of their GLP-1 weight loss drugs Wegovy and Zepbound, a move that could make them more affordable for millions of people. | NBC News

A press conference was interrupted on Thursday when a drug executive fainted in the Oval Office while President Donald Trump was announcing a deal with drugmakers to lower the cost of obesity drugs. On Thursday, Trump and drugmakers were speaking to the press regarding a deal with Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy. David Ricks, Eli Lilly’s CEO, was giving remarks when he looked to his right and said, “Are you